← All trials
NCT01072864
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2010
- Primary completion
- Aug 31, 2010
- Completion date
- Sep 30, 2010
- First posted
- Feb 22, 2010
- Last posted
- Nov 1, 2010
- Enrollment
- 5
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of California, DavisLead sponsor
- University of California, DavisOverall official - principal investigator
- University of California, DavisSponsor investigator
- California Walnut CommissionCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.